.png){kind=icon}
X
Xinrui Yang
H指数:23
被引数:1,622
浏览量:0
个人简介
暂无内容
教育背景
暂无内容
工作经历
暂无内容
荣誉奖项
暂无内容
Correction: Pei et al. Fluid Shear Stress Regulates Osteogenic Differentiation via AnnexinA6-Mediated Autophagy in MC3T3-E1 Cells. Int. J. Mol. Sci. 2022, 23, 15702
更正：Pei等人. 流体剪切应力通过AnnexinA6介导的自噬调控MC3T3-E1细胞的成骨分化. Int. J. Mol. Sci. 2022, 23, 15702
Bibliometric analysis of research on traditional Chinese medicine for prevention and treatment of myocardial fibrosis from 2008 to 2025 based on Web of Science database
基于Web of Science数据库的2008年至2025年传统中医药防治心肌纤维化研究的文献计量学分析
Medicine
IF1.4
In vitro antimicrobial activity of six novel β-lactam and β-lactamase inhibitor combinations and cefiderocol against NDM-producing Enterobacterales in China
中国NDM产生菌肠杆菌科细菌中六种新型β-内酰胺与β-内酰胺酶抑制剂组合以及cefiderocol的体外抗菌活性
Urokinase-loaded Pt quantum dot self-assembled nanoparticles for inflammation elimination and fibrinolytic thrombus therapy
尿激酶负载的Pt量子点自组装纳米颗粒用于消除炎症和纤维蛋白溶解性血栓治疗
Discovery and Engineering of the L-Threonine Aldolase from Neptunomonas marine for the Efficient Synthesis of ß-Hydroxy-α-amino Acids via C-C Formation
海洋nptunomonas的L-苏氨酸醛缩酶的发现和工程改造，通过c-c形成有效合成 ß-羟基-α-氨基酸
ACS CATALYSIS
IF13.1
Translational relevance of SOS1 targeting for KRAS-mutant colorectal cancer
SOS1靶向治疗KRAS突变型结直肠癌的翻译相关性
Development of SOS1 Inhibitor-Based Degraders to Target KRAS-Mutant Colorectal Cancer
开发基于SOS1抑制剂的降解剂以靶向KRAS突变的结直肠癌
